Sign in

CIK 0001811063

  • Non-accelerated filer
  • Smaller reporting company

Nuvation Bio Inc.

Sign in to watch
Ticker
NUVB
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850862255
Phone
+1 332-208-6102
Business address
1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
Former names
Panacea Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-27 Hung David PRESIDENT AND CEO Grant or award · Stock Option (Right to Buy) +1,995,012 1,995,012
2025-06-16 Hung David PRESIDENT AND CEO Purchase +500,000 $1.79 $894K 59,281,054
2025-04-07 Hung David PRESIDENT AND CEO Purchase +300,000 $1.63 $488K 58,781,054
2025-04-04 Hung David PRESIDENT AND CEO Purchase +200,000 $1.66 $333K 58,481,054
2025-02-28 Hung David PRESIDENT AND CEO Grant or award · Stock Option (Right to Buy) +2,000,000 2,000,000
2024-02-29 Hung David PRESIDENT AND CEO Grant or award · Stock Option (Right to Buy) +2,000,000 2,000,000
2023-02-28 Hung David President and CEO Grant or award · Stock Option (Right to Buy) +2,500,000 2,500,000
2022-02-28 Hung David President and CEO Grant or award · Stock Option (Right to Buy) +2,000,000 2,000,000
2021-03-09 Hung David President and CEO Grant or award · Stock Option (Right to Buy) +165,465 165,465
2021-03-09 Hung David President and CEO Grant or award · Stock Option (Right to Buy) +224,760 224,760
2021-03-02 Hung David President and CEO Other disposition −368,408 58,281,054
2021-02-10 Hung David President and CEO Grant or award +56,645,012 56,645,012
2021-02-10 Hung David President and CEO Grant or award +2,000,000 $10.00 $20.0M 58,645,012
2021-02-10 Hung David President and CEO Grant or award · Class B Common Stock +1,000,000 1,000,000

Page 1 of 1 · 14 trades